Abstract
In an effort to develop new and more effective therapies to treat bacterial infection, quinolone coupled benzothiazoles (6a-f) have prepared and evaluated for their efficacy as antibacterial agents against various Gram-positive and Gram-negative strains of bacteria. Some of the compounds from this series exhibited antibacterial activity comparable to ciprofloxacin.
Keywords: Benzothiazoles, Quinolones, Antibacterial activity
Letters in Drug Design & Discovery
Title: Synthesis and Biological Evaluation of a New Series of Benzothiazole-Quinolone Hybrids as Antibacterial Agents
Volume: 5 Issue: 5
Author(s): Ahmed Kamal, S. Kaleem Ahmed, M. Naseer A. Khan, Rajesh V.C.R.N.C. Shetty, B. Siddhardha and U. S.N. Murty
Affiliation:
Keywords: Benzothiazoles, Quinolones, Antibacterial activity
Abstract: In an effort to develop new and more effective therapies to treat bacterial infection, quinolone coupled benzothiazoles (6a-f) have prepared and evaluated for their efficacy as antibacterial agents against various Gram-positive and Gram-negative strains of bacteria. Some of the compounds from this series exhibited antibacterial activity comparable to ciprofloxacin.
Export Options
About this article
Cite this article as:
Kamal Ahmed, Ahmed Kaleem S., A. Khan Naseer M., Shetty V.C.R.N.C. Rajesh, Siddhardha B. and Murty S.N. U., Synthesis and Biological Evaluation of a New Series of Benzothiazole-Quinolone Hybrids as Antibacterial Agents, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912072
DOI https://dx.doi.org/10.2174/157018008784912072 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Bioinformatics Used to Predict the Protein Targets of
Remdesivir and Flavones in SARS-CoV-2 Infection
Medicinal Chemistry Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants
Combinatorial Chemistry & High Throughput Screening Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines
Current Stem Cell Research & Therapy Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic
Reviews on Recent Clinical Trials The Association of Chemotherapy and Radiotherapy: Breast Cancer
Current Drug Therapy Glibenclamide Action on Myocardial Function and Arrhythmia Incidence in the Healthy and Diabetic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives
Mini-Reviews in Medicinal Chemistry Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update
Current Medicinal Chemistry Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets Prediction of Enzyme’s Family Based on Protein-Protein Interaction Network
Current Bioinformatics Hit Triage Using Efficiency Indices after Screening of Compound Libraries in Drug Discovery
Current Topics in Medicinal Chemistry New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Current Topics in Medicinal Chemistry COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: A Proposed Classification and Treatment Strategies
Infectious Disorders - Drug Targets Vitamin C and D Supplements to Prevent the Risk of COVID-19
The Natural Products Journal Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors
Current Drug Discovery Technologies Perspective on Aggregation-induced Emission (AIE) Materials for Pathogen Detection
Current Analytical Chemistry Recent Progress in the Design of Selectin Inhibitors
Mini-Reviews in Medicinal Chemistry Discoveries of Tat-TAR Interaction Inhibitors for HIV-1
Current Drug Targets - Infectious Disorders